The kynurenine pathway in adolescent depression: Preliminary findings from a proton MR spectroscopy study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 1, 2010, Pages 37-44

  Gabbay, Vilma ^a,b   Liebes, Leonard ^c   Katz, Yisrael ^a   Liu, Songtao ^d   Mendoza, Sandra ^c   Babb, James S ^d   Klein, Rachel G ^a   Gonen, Oded ^d  

^a NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescent MDD; Choline; Kynurenine pathway; Melancholic; MR Spectroscopy; Striatum

Indexed keywords

3 HYDROXYANTHRANILIC ACID; CHOLINE; KYNURENINE; TRYPTOPHAN;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN LEVEL; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE DISPLAY; MALE; MELANCHOLIA; PROTON NUCLEAR MAGNETIC RESONANCE; PUTAMEN;

3-HYDROXYANTHRANILIC ACID; ADOLESCENT; ASPARTIC ACID; BRAIN; BRAIN MAPPING; CHOLINE; DEPRESSION; FEMALE; HUMANS; KYNURENINE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEURAL PATHWAYS; PSYCHIATRIC STATUS RATING SCALES; STATISTICS, NONPARAMETRIC; TRYPTOPHAN; YOUNG ADULT;

EID: 73649114218     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.09.015     Document Type: Article

References (52)

1. Anderson I.M., Parry-Billings M., Newsholme E.A., Poortmans J.R., and Cowen P.J. Decreased plasma tryptophan concentration in major depression: relationship to melancholia and weight loss. J Affect Disord 20 (1990) 185-191
2. Baumann B., Danos P., Krell D., Diekmann S., Leschinger A., Stauch R., et al. Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. J Neuropsychiatry Clin Neurosci 11 (1999) 71-78
3. Bernstein M.A., Fain S.B., and Riederer S.J. Effect of windowing and zero-filled reconstruction of MRI data on spatial resolution and acquisition strategy. J Magn Reson Imaging 14 (2001) 270-280
4. Caetano S.C., Fonseca M., Olvera R.L., Nicoletti M., Hatch J.P., Stanley J.A., et al. Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients. Neurosci Lett 384 (2005) 321-326
5. Capuron L., Neurauter G., Musselman D.L., Lawson D.H., Nemeroff C.B., and Fuchs D. et al. Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry 54 (2003) 906-914
6. Capuron L., Ravaud A., Neveu P.J., Miller A.H., Maes M., and Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7 (2002) 468-473
7. Charles H.C., Lazeyras F., Krishnan K.R., Boyko O.B., Payne M., and Moore D. Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry 18 (1994) 1121-1127
8. Curzon G., and Bridges P.K. Tryptophan metabolism in depression. J Neurol Neurosurg Psychiatry 33 (1970) 698-704
9. Du Y.P., Parker D.L., Davis W.L., and Cao G. Reduction of partial-volume artifacts with zero-filled interpolation in three-dimensional MR angiography. J Magn Res Imaging 4 (1994) 733-741
10. Ebel A., Dreher W., and Leibfritz D. Effects of zero-filling and apodization on spectral integrals in discrete Fourier-transform spectroscopy of noisy data. J Magn Reson 182 (2006) 330-338
11. Farchione T.R., Moore G.J., and Rosenberg D.R. Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biol Psychiatry 52 (2002) 86-92
12. Forbes E.E., Hariri A.R., Martin S.L., Silk J.S., Moyles D.L., Fisher P.M., et al. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry 166 (2009) 64-73
13. Gabbay V., Hess D.A., Liu S., Babb J.S., Klein R.G., and Gonen O. Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study. Am J Psychiatry 164 (2007) 1881-1889
14. Gabbay V., Klein R.G., Alonso C.M., Babb J.S., Nishawala M., De Jesus G., et al. Immune system dysregulation in adolescent major depressive disorder. J Affect Disord 115 (2009) 177-182
15. Goelman G., Liu S., Fleysher R., Fleysher L., Grossman R.I., and Gonen O. Chemical-shift artifact reduction in Hadamard-encoded MR spectroscopic imaging at high (3 T and 7 T) magnetic fields. Magn Reson Med 58 (2007) 167-173
16. Goelman G., Liu S., Hess D., and Gonen O. Optimizing the efficiency of high-field multivoxel spectroscopic imaging by multiplexing in space and time. Magn Reson Med 56 (2006) 34-40
17. Goldstein L.E., Leopold M.C., Huang X., Atwood C.S., Saunders A.J., Hartshorn M., et al. 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction. Biochemistry 39 (2000) 7266-7275
18. Hamakawa H., Kato T., Murashita J., and Kato N. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci 248 (1998) 53-58
19. Hercher C., Turecki G., and Mechawar N. Through the looking glass: examining neuroanatomical evidence for cellular alterations in major depression. J Psychiatr Res 43 (2009) 947-961
20. Hu J., Javaid T., Arias-Mendoza F., Liu Z., McNamara R., and Brown T.R. A fast, reliable, automatic shimming procedure using 1H chemical-shift-imaging spectroscopy. J Magn Reson B 108 (1995) 213-219
21. Inglese M., Li B.S., Rusinek H., Babb J.S., Grossman R.I., and Gonen O. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn Reson Med 50 (2003) 190-195
22. Irwin M.R., and Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 21 (2007) 374-383
23. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psych 36 (1997) 980-988
24. Kim M.J., Hamilton J.P., and Gotlib I.H. Reduced caudate gray matter volume in women with major depressive disorder. Psychiatry Res 164 (2008) 114-122
25. Kirov I., Fleysher L., Fleysher R., Patil V., Liu S., and Gonen O. Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T. Magn Reson Med 60 (2008) 790-795
26. Kusumakar V., MacMaster F.P., Gates L., Sparkes S.J., and Khan S.C. Left medial temporal cytosolic choline in early onset depression. Can J Psychiatry 46 (2001) 959-964
27. Lacerda A.L., Nicoletti M.A., Brambilla P., Sassi R.B., Mallinger A.G., Frank E., et al. Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res 124 (2003) 129-140
28. Loffelholz K., Klein J., and Koppen A. Choline, a precursor of acetylcholine and phospholipids in the brain. Prog Brain Res 98 (1993) 197-200
29. Maes M., Scharpe S., Meltzer H.Y., Okayli G., Bosmans E., D'Hondt P., et al. Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Psychiatry Res 54 (1994) 143-160
30. Maes M., Wauters A., Verkerk R., Demedts P., Neels H., Van Gastel A., et al. Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism. Neuropsychopharmacology 15 (1996) 243-251
31. Matsuo K., Rosenberg D.R., Easter P.C., MacMaster F.P., Chen H.H., Nicoletti M., et al. Striatal volume abnormalities in treatment-naive patients diagnosed with pediatric major depressive disorder. J Child Adolesc Psychopharmacol 18 (2008) 121-131
32. Miller D.H., Albert P.S., Barkhof F., Francis G., Frank J.A., Hodgkinson S., et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol 39 (1996) 6-16
33. Myint A.M., Kim Y.K., Verkerk R., Scharpe S., Steinbusch H., and Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 98 (2007) 143-151
34. O'Connor J.C., Lawson M.A., Andre C., Moreau M., Lestage J., Castanon N., et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2, 3-dioxygenase activation in mice. Mol Psychiatry 14 (2009) 511-522
35. Okuda S., Nishiyama N., Saito H., and Katsuki H. 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem 70 (1998) 299-307
36. Parker D.L., Du Y.P., and Davis W.L. The voxel sensitivity function in fourier transform imaging: application to magnetic rersonance angiography. Magn Reson Med 32 (1995) 156-160
37. Perkins M.N., and Stone T.W. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res 247 (1982) 184-187
38. Petty F., Kramer G.L., Gullion C.M., and Rush A.J. Low plasma gamma-aminobutyric acid levels in male patients with depression. Biol Psychiatry 32 (1992) 354-363
39. Renshaw P.F., Lafer B., Babb S.M., Fava M., Stoll A.L., Christensen J.D., et al. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 41 (1997) 837-843
40. Roy A., Dejong J., and Ferraro T. CSF GABA in depressed patients and normal controls. Psychol Med 21 (1991) 613-618
41. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.T., Appel M., Rothman D.L., et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch General Psychiatry 61 (2004) 705-713
42. Sapko M.T., Guidetti P., Yu P., Tagle D.A., Pellicciari R., and Schwarcz R. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington's disease. Exp Neurol 197 (2006) 31-40
43. Schwarcz R., Whetsell Jr. W.O., and Mangano R.M. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219 (1983) 316-318
44. Soher B.J., Young K., Govindaraju V., and Maudsley A.A. Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 40 (1998) 822-831
45. Steingard R.J., Yurgelun-Todd D.A., Hennen J., Moore J.C., Moore C.M., Vakili K., et al. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry 48 (2000) 1053-1061
46. Tavares R.G., Tasca C.I., Santos C.E., Alves L.B., Porciuncula L.O., Emanuelli T., et al. Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem Int 40 (2002) 621-627
47. Traber F., Block W., Lamerichs R., Gieseke J., and Schild H.H. 1H metabolite relaxation times at 3.0 Tesla: measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 19 (2004) 537-545
48. Tremblay L.K., Naranjo C.A., Graham S.J., Herrmann N., Mayberg H.S., Hevenor S., et al. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 62 (2005) 1228-1236
49. Urenjak J., Williams S.R., Gadian D.G., and Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13 (1993) 981-989
50. Vythilingam M., Charles H.C., Tupler L.A., Blitchington T., Kelly L., and Krishnan K.R. Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study. Biol Psychiatry 54 (2003) 744-750
51. Wichers M.C., Koek G.H., Robaeys G., Verkerk R., Scharpe S., and Maes M. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry 10 (2005) 538-544
52. Yildiz-Yesiloglu A., and Ankerst D.P. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res 147 (2006) 1-25